MEC Plus Full List View

MEC Plus

Biomarkers in NSCLC: Current Status and Future Directions
Biomarkers in NSCLC: Current Status and Future Directions
Philip Mack, PhD
Ovarian Cancer Update: PARP Inhibitors in Ovarian Cancer
Ovarian Cancer Update: PARP Inhibitors in Ovarian Cancer
Elizabeth Diver, MD
Optimizing Immunotherapy with Radiation
Optimizing Immunotherapy with Radiation
Megan Daly, MD
Cutaneous Melanoma, New Developments for 2018 and Beyond
Cutaneous Melanoma, New Developments for 2018 and Beyond
Kim Margolin, MD
Acute Myeloid and Lymphoid Leukemias
Acute Myeloid and Lymphoid Leukemias
Kevin Kelley, MD, PhD
Immunotherapy for Advanced NSCLC
Immunotherapy for Advanced NSCLC
Karen Reckamp, MD
What's New in Hematopoietic Stem Cell Transplantation?
What's New in Hematopoietic Stem Cell Transplantation?
Joseph Tuscano, MD
Targeted Therapy for NSCLC
Targeted Therapy for NSCLC
Jonathan Riess, MD, MS
Lung Cancer Case
Lung Cancer Case
Jonathan Riess, MD, MS
Colon Cancer: State of the Art
Colon Cancer: State of the Art
Heinz-Josef Lenz, MD
New Developments in Pancreatic Cancer
New Developments in Pancreatic Cancer
Edward Kim, MD
Predictive Biomarkers for Immunotherapy: Non-Small Cell Lung Cancer as a Model of Tumor Heterogeneity
Predictive Biomarkers for Immunotherapy: Non-Small Cell Lung Cancer as a Model of Tumor Heterogeneity
David Gandara, MD
A Complicated Case of Gastric Cancer
A Complicated Case of Gastric Cancer
Afsaneh Barzi, MD, PhD
Challenging Case #2: Genitourinary Cancer
Challenging Case #2: Genitourinary Cancer
Mamta Parikh, MD, MS
Systemic Immunotherapy Combinations
Systemic Immunotherapy Combinations
Arta M Monjazeb, MD, PhD
Hepatocellular Cancer: Latest Advances
Hepatocellular Cancer: Latest Advances
Anthony El-Khoueiry, MD
Updates in Multiple Myeloma
Updates in Multiple Myeloma
Aaron Rosenburg, MD, MS
Emerging Systematic Treatments for Head and Neck Cancers
Emerging Systematic Treatments for Head and Neck Cancers
Dimitrios Colevas, MD
ER/PR Breast Disease: Early Stage, Locally Advanced and Metastatic Breast Cancer
ER/PR Breast Disease: Early Stage, Locally Advanced and Metastatic Breast Cancer
Vicente Valero, MD, FACP
Gynecologic Cancer
Gynecologic Cancer
Tate Thigpen, MD
EGFR: Common and Uncommon Mutations and What Is Next for This Patient Population
EGFR: Common and Uncommon Mutations and What Is Next for This Patient Population
Edgardo S Santos, MD, FACP
ALK-Altered Non-Squamous NSCLC: Options and Sequence
ALK-Altered Non-Squamous NSCLC: Options and Sequence
Jacob Sands, MD
Updates in the Management of HER-2 Positive Breast Cancer
Updates in the Management of HER-2 Positive Breast Cancer
Hope S Rugo, MD
How to Handle the Onco-Geriatric Patient: Facts and Myth
How to Handle the Onco-Geriatric Patient: Facts and Myth
Thomas Reske, MD, PhD, CMD, FACP
Incorporating Immunotherapy and Novel Biological Agents in Breast Cancer: New Horizons
Incorporating Immunotherapy and Novel Biological Agents in Breast Cancer: New Horizons
Mark Pegram, MD
Surfing Between Therapeutic Options For HRPC
Surfing Between Therapeutic Options For HRPC
Daniel Petrylak, MD
Update on the Treatment of Small Cell Lung Cancer and Neuroendocrine Lung Cancers
Update on the Treatment of Small Cell Lung Cancer and Neuroendocrine Lung Cancers
Ronald B Natale, MD
Squamous Cell Carcinoma Standard and Novel Targets
Squamous Cell Carcinoma Standard and Novel Targets
Mohamed K Mohamed, MD, PhD
The New Face of Oral Cancer
The New Face of Oral Cancer
Robert E Marx, DDS